NORML recently announced that according to a keyword search, there were more than 4,300 scientific research papers published about cannabis in 2022. In 2021, there were an estimated 4,200 papers published; over the last 12 years, more than 30,000 research papers have now been published; and in total, there are approximately 42,500 scientific papers exploring cannabis.

While it’s common to hear opponents of cannabis state that more research is necessary before legalization can occur, NORML Deputy Director Paul Armentano released a statement to counter that argument. “Despite claims by some that marijuana has yet to be subject to adequate scientific scrutiny, scientists’ interest in studying cannabis has increased exponentially in recent years, as has our understanding of the plant, its active constituents, their mechanisms of action, and their effects on both the user and upon society,” Armentano said. “It is time for politicians and others to stop assessing

Read More

MEDICAL FAIR ASIA continues to be Southeast Asia’s most definitive occasion for the medical and healthcare industry, gathering the region’s hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors in a single convenient location and offering the perfect platform to discover the newest trade improvements, to network and do enterprise.

Sure, I can honestly say that I deal with each patient as I might need my family members to be treated. Additionally it is what I educate when I’ve college students working with me. I know not all nurses are like that but that was why I grew to become a nurse, because of both excellent care and dangerous care I acquired during my first pregnancy. You might say I used to be each inspired and disgusted. I wished to deal with folks the best way I wanted to be treated. Funny factor is, not everyone desires to be handled the way …

Read More

It’s time once again to officially announce that the High Times Hemp Cup: People’s Choice Edition is coming soon! Since 2020, we’ve celebrated a variety of different High Times People’s Choice Cups and can’t wait to see what’s in store for this one. While many of our other People’s Choice competitions focus on products from a single market, the Hemp Cup covers competitors throughout the entire country. We’re calling on everyone to put their best products forward.

This year, we’re upgrading the categories in the High Times Hemp Cup by welcoming three legal psychoactive groups that will make the selection of offerings even more irresistible.


Hemp-Derived CBD Edibles: Gummies & Fruit Chews (NON-PSYCHOACTIVE ONLY) 
Hemp-Derived CBD Edibles: Non-Gummies (NON-PSYCHOACTIVE ONLY) (No Liquids above 1 FL OZ allowed)
Hemp-Derived CBD Tinctures + Capsules (NON-PSYCHOACTIVE

Read More

Monday Grammy Award-winning artist Stephen Marley announced Kx Family Care, a plant-based, CBD personal care line—utilizing the power of hemp and other herbs used traditionally in Jamaica.

The debut collection features a limited edition holiday bundle, including two products: multipurpose Hair and Beard Oil and the Pain Relief Balm. The Hair and Beard Oil and the Pain Relief Balm contain full-spectrum CBD oil, used for its anti-inflammatory, antibacterial, and antioxidant properties. 

Both products also contain sunflower oil, vitamin E, and linoleic acid, which contain antioxidants that help protect the skin from free radicals and maintain its natural barrier. They also contain Black Seed oil, Mangosteen extract, and Soursop—widely used in Jamaican culture for their regenerative properties.

Jamaican Black Seed oil, for instance, is derived from fennel (Nigella sativa), is high in antioxidants and provides several other health benefits.

“Due to my love for the hemp plant

Read More

Enthea, the healthcare provider that specializes in psychedelic therapy, announced on Tuesday that it will “launch its services into 40 markets across the U.S. next year as well as grow Enthea’s customer base and provider network to further its mission of providing affordability and access to safe and effective psychedelic-assisted therapies for all who can benefit.”

The ambitious launch is the byproduct of a “successful $2M seed round raise, led by Tabula Rasa Ventures, the first psychedelic accelerator for early-stage startups,” the company said in the announcement. 

Enthea says that the driving force behind the new endeavor is to improve access to potentially breakthrough psychedelic treatment amid an ever-spiraling mental health crisis in the United States. 

The company asserts that it is “helping in this mental health crisis by bringing employer funding for these new treatments,” saying that “traditional health insurers are years away from adding this coverage, the cost

Read More